SCHEMBL21667279

SCHEMBL21667279

CC(C)n1c(=O)cc(NCc2ccccc2Cl)[nH]c1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.54
▸ CYP2B6 P20813 1/20 0.54
▸ PDE9A O76083 2/20 0.47
▸ FABP4 P15090 1/20 0.41
▸ POLB P06746 3/20 0.41
▸ LMNA P02545 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ TP53 P04637 2/20 0.40
▸ GPR84 Q9NQS5 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ PIK3CA P42336 1/20 0.39
▸ PIK3CB P42338 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ THRB P10828 1/20 0.38
▸ HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21667323 0.87 CYP3A4 (0.54) CYP3A4CYP2B6POLBLMNATP53
SCHEMBL21667337 0.86 CYP3A4 (0.53) CYP3A4CYP2B6POLBLMNACYP2C19
SCHEMBL21667350 0.86 CYP3A4 (0.53) CYP3A4CYP2B6LMNATP53KMT2A
SCHEMBL21667335 0.84 CYP3A4 (0.51) CYP3A4CYP2B6PDE9AHSD17B10KMT2A
SCHEMBL21667318 0.83 CYP3A4 (0.50) CYP3A4CYP2B6LMNATP53SMN1; SMN2
SCHEMBL21667363 0.83 CYP3A4 (0.50) CYP3A4CYP2B6THRB
SCHEMBL20716038 0.83 CYP3A4 (0.61) CYP3A4CYP2B6PDE9APOLBLMNA
SCHEMBL21667306 0.79 CYP3A4 (0.50) CYP3A4CYP2B6PDE9AFABP4POLB
SCHEMBL24469599 0.78 CYP3A4 (0.45) CYP3A4CYP2B6POLBLMNATP53
SCHEMBL21667339 0.78 CYP3A4 (0.46) CYP3A4CYP2B6POLBLMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3702352-A1 PYRIMIDINEDIONE COMPOUND AGAINST CARDIAC CONDITIONS Myokardia, Inc. (US) 2020-09-02 — — EP disclosed
EP-3010910-B1 PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS MYOKARDIA INC (US) 2020-02-05 — — EP disclosed
Send feedback